Hepatocyte Growth Factor Enhances Antineoplastic Effect of 5-Fluorouracil by Increasing UPP1 Expression in HepG2 Cells

被引:4
|
作者
Okumura, Manabu [1 ,2 ]
Iwakiri, Tomomi [1 ]
Yoshikawa, Naoki [1 ]
Nagatomo, Takao [1 ]
Ayabe, Takanori [2 ,3 ]
Tsuneyoshi, Isao [2 ,4 ]
Ikeda, Ryuji [1 ]
机构
[1] Univ Miyazaki, Fac Med, Dept Pharm, Miyazaki 8891692, Japan
[2] Miyazaki Univ Hosp, Dept Patient Safety Management, Miyazaki 8891692, Japan
[3] Univ Miyazaki, Fac Med, Dept Surg, Div Thorac & Breast Surg, Miyazaki 8891692, Japan
[4] Univ Miyazaki, Fac Med, Dept Anesthesiol & Intens Care, Miyazaki 8891692, Japan
关键词
hepatocyte growth factor; HGF; 5-FU; UPP1; c-Met; erlotinib; RECEPTOR TYROSINE KINASE; C-MET; URIDINE PHOSPHORYLASE; OVEREXPRESSION; AMPLIFICATION; BINDING; CANCER; RILOTUMUMAB; SUPPRESSES; ACTIVATION;
D O I
10.3390/ijms23169108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant activation of hepatocyte growth factor (HGF) and its receptor c-Met axis promotes tumor growth. Therefore, many clinical trials have been conducted. A phase 3 trial investigating a monoclonal antibody targeting HGF in combination with fluoropyrimidine-based chemotherapy had to be terminated prematurely; however, the reason behind the failure remains poorly defined. In this study, we investigated the influence of HGF on the antineoplastic effects of 5-fluorouracil (5-FU), a fluoropyrimidine, in HepG2 cells. HGF suppressed the proliferative activity of cells concomitantly treated with 5-FU more robustly as compared to that of cells treated with 5-FU alone, and markedly increased the expression of uridine phosphorylase 1 (UPP1). Intracellular concentration of 5-fluorouridine, an initial anabolite of 5-FU catalyzed by UPP1, was increased by HGF. Interestingly, erlotinib enhanced HGF-induced increase in UPP1 mRNA; in contrast, gefitinib suppressed it. Furthermore, erlotinib suppressed HGF-increased phosphorylation of the epidermal growth factor receptor at the Tyr1173 site involved in downregulation of extracellular signal-regulated kinase (Erk) activation, and enhanced the HGF-increased phosphorylation of Erk. Collectively, these findings suggest that inhibition of the HGF/c-Met axis diminishes the effects of fluoropyrimidine through downregulation of UPP1 expression. Therefore, extreme caution must be exercised in terms of patient safety while offering chemotherapy comprising fluoropyrimidine concomitantly with inhibitors of the HGF/c-Met axis.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells
    Papavee Samatiwat
    Auemduan Prawan
    Laddawan Senggunprai
    Veerapol Kukongviriyapan
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, 388 : 601 - 612
  • [42] Influence of 5-fluorouracil on colonic healing and expression of transforming growth factor-beta 1
    Fukuchi, SG
    Seeburger, JL
    Parquet, G
    Rolandelli, RH
    JOURNAL OF SURGICAL RESEARCH, 1999, 84 (02) : 121 - 126
  • [43] HCV core protein activates expression of vascular endothelial growth factor in HepG2 cells
    刘重阳
    刘为纹
    杨建民
    房殿春
    中华肝脏病杂志, 2001, (04) : 214 - 216
  • [44] Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability
    Juan, Hsien-Chia
    Tsai, Hsin-Ting
    Chang, Po-Hao
    Huang, Chi-Ying F.
    Hu, Cheng-Po
    Wong, Fen-Hwa
    APOPTOSIS, 2011, 16 (02) : 174 - 183
  • [45] Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability
    Hsien-Chia Juan
    Hsin-Ting Tsai
    Po-Hao Chang
    Chi-Ying F. Huang
    Cheng-Po Hu
    Fen-Hwa Wong
    Apoptosis, 2011, 16 : 174 - 183
  • [46] Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice
    Li Zhao
    Zhen Chen
    Jun Wang
    Li Yang
    Qing Zhao
    Jia Wang
    Qi Qi
    Rong Mu
    Qi-Dong You
    Qing-Long Guo
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 481 - 489
  • [47] Effect of hypoxia on hypoxia inducible factor-1α, insulin-like growth factor I and vascular endothelial growth factor expression in hepatocellular carcinoma HepG2 cells
    Liu, Qiang
    Xu, Zheng
    Mao, Shunbao
    Chen, Wenyou
    Zeng, Rongyao
    Zhou, Song
    Liu, Jing
    ONCOLOGY LETTERS, 2015, 9 (03) : 1142 - 1148
  • [48] Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice
    Zhao, Li
    Chen, Zhen
    Wang, Jun
    Yang, Li
    Zhao, Qing
    Wang, Jia
    Qi, Qi
    Mu, Rong
    You, Qi-Dong
    Guo, Qing-Long
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 481 - 489
  • [49] ENHANCEMENT OF VITRONECTIN EXPRESSION IN HUMAN HEPG2 HEPATOMA-CELLS BY TRANSFORMING GROWTH FACTOR-BETA-1
    KOLI, K
    LOHI, J
    HAUTANEN, A
    KESKIOJA, J
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 199 (02): : 337 - 345
  • [50] Expression of Therapeutic Gene FCU1 Sensitizes Pancreatic Cancer Cells to 5-Fluorocytosine and Enhances the Cytotoxic Effect of 5-Fluorouracil
    Kopantsev, E. P.
    Kostina, M. B.
    Grankina, E. V.
    Kopantseva, M. R.
    Egorov, V. I.
    Sverdlov, E. D.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 161 (06) : 808 - 810